T cell development, ageing and Interleukin-7

Interleukin-7 (IL-7) is a cytokine with a central role in the development and maintenance of the peripheral T cell pool. In the mouse, expression of the IL-7 gene in the thymus has been carefully followed from gestation onwards throughout the lifespan. One of the features of its expression in the thymus is that it changes with time, declining measurably as the animal ages. This reduction is associated with a decrease in thymic size, cellularity and output. Analysis of transgenic animals carrying either IL-7 or IL-7 receptor transgenes reveals that the intrathymic level of IL-7 has a critical effect on the production of T cells, and that this may not be a linear relationship. This is an important consideration for therapy involving treatment of old animals with IL-7 of which there are reports indicating some rejuvenation of the thymus following IL-7 treatment, which is never complete. The thymus does not appear to return to the size and cellularity seen in youth. Several possible scenarios could account for this, including the inability to maintain IL-7 within defined limits in the thymus during the therapy.

[1]  K. Muegge,et al.  The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. , 1998, Journal of immunology.

[2]  K. Muegge,et al.  Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. , 1993, Science.

[3]  L. Brunton,et al.  Characterization of the human and murine IL-7 genes. , 1990, Journal of immunology.

[4]  G. Gorgun,et al.  Structure function analysis of interleukin 7: requirement for an aromatic ring at position 143 of helix D. , 2002, Cytokine.

[5]  J. Stechmiller,et al.  Nutritional Formula Enhanced Immune Function and Reduced Days of Symptoms of Upper Respiratory Tract Infection in Seniors , 2004, Journal of the American Geriatrics Society.

[6]  T. Conlon,et al.  Recombinant adeno-associated virus vectors for gene therapy , 2004, Expert opinion on biological therapy.

[7]  K. Ariizumi,et al.  IFN-gamma-dependent IL-7 gene regulation in keratinocytes. , 1995, Journal of immunology.

[8]  C. March,et al.  Stimulation of B-cell progenitors by cloned murine interleukin-7 , 1988, Nature.

[9]  K. Dittmar,et al.  Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. , 2002, International immunology.

[10]  T. Fry,et al.  Interleukin-7 and immunorestoration in HIV: beyond the thymus. , 2002, Journal of hematotherapy & stem cell research.

[11]  G. Leclercq,et al.  Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture. , 1993, Journal of immunology.

[12]  D. Chitayat,et al.  A partial deficiency of interleukin-7Rα is sufficient to abrogate T-cell development and cause severe combined immunodeficiency , 2000 .

[13]  T. Moore,et al.  Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. , 1996, Journal of immunology.

[14]  A. George,et al.  Selection of antibodies to cell surface determinants on mouse thymic epithelial cells using a phage display library , 1997, Immunology.

[15]  R. Aspinall,et al.  Age-associated thymic atrophy is not associated with a deficiency in the CD44(+)CD25(-)CD3(-)CD4(-)CD8(-) thymocyte population. , 2001, Cellular immunology.

[16]  N. Solvason,et al.  The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. , 1997, Immunity.

[17]  J. Robinson.  The ontogeny of antigen-presenting cells in fetal thymus evaluated by MLR stimulation. , 1983, Journal of immunology.

[18]  T. Fry,et al.  Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. , 2005, The Journal of clinical investigation.

[19]  Chauca A. English,et al.  IL-7 Gene Therapy in Aging Restores Early Thymopoiesis without Reversing Involution , 2004, Journal of Immunology.

[20]  R Murray,et al.  Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class-II-expressing thymic stromal cells. , 1997, Immunity.

[21]  A. Fischer,et al.  The Common Cytokine Receptor γ Chain and the Pre-T Cell Receptor Provide Independent but Critically Overlapping Signals in Early α/β T Cell Development , 1999, The Journal of experimental medicine.

[22]  Li Wu,et al.  CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus , 1991, Nature.

[23]  R. Aspinall,et al.  Age-associated thymic atrophy is linked to a decline in IL-7 production , 2002, Experimental Gerontology.

[24]  Yili Yang,et al.  Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. , 2004, Blood.

[25]  Heinz Baumann,et al.  Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin , 2000, Nature Immunology.

[26]  M. Wiles,et al.  Interleukin‐7 expression during mouse thymus development , 1992, European journal of immunology.

[27]  G. Anderson,et al.  Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction , 1993, European journal of immunology.

[28]  C. Carini,et al.  Dysregulation of interleukin‐7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection , 1994, European journal of immunology.

[29]  D. Schatz,et al.  Multiple rearrangements in T cell receptor alpha chain genes maximize the production of useful thymocytes , 1993, The Journal of experimental medicine.

[30]  M. Michaelson,et al.  Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. , 1996, Developmental biology.

[31]  R. Aspinall,et al.  Molecular quantitation of thymic output in mice and the effect of IL‐7 , 2002, European journal of immunology.

[32]  Temple F. Smith,et al.  Comparative model building of interleukin‐7 using interleukin‐4 as a template: A structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation , 2000, Protein science : a publication of the Protein Society.

[33]  P. Morrissey,et al.  Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. , 1991, Journal of immunology.

[34]  P. Morrissey,et al.  Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. , 1996, Journal of immunology.

[35]  A. Zlotnik,et al.  A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. , 1993, Journal of immunology.

[36]  T. Waldschmidt,et al.  The effect of in vivo IL-7 deprivation on T cell maturation , 1995, The Journal of experimental medicine.

[37]  R. Ho,et al.  Differential Disposition of Soluble and Liposome-Formulated Human Recombinant Interleukin-7: Effects on Blood Lymphocyte Population in Guinea Pigs , 1994, Pharmaceutical Research.

[38]  H. Fehling,et al.  Early αβ T cell development in the thymus of normal and genetically altered mice , 1997 .

[39]  K. Kaushansky,et al.  IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. , 2003, The Journal of allergy and clinical immunology.

[40]  D. Williams,et al.  Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. , 1991, Journal of immunology.

[41]  A. Bhandoola,et al.  Thymopoiesis independent of common lymphoid progenitors , 2003, Nature Immunology.

[42]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[43]  Kenneth M. Yamada,et al.  Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix‐bound interleukin‐7 , 1997, European journal of immunology.

[44]  M. Dallman,et al.  Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. , 1991, Journal of immunology.

[45]  T. Fry,et al.  Interleukin-7: from bench to clinic. , 2002, Blood.

[46]  C. Benoist,et al.  Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. , 1997, Immunity.

[47]  D. Spray,et al.  Functional gap junctions in thymic epithelial cells are formed by connexin 43 , 1995, European journal of immunology.

[48]  R. Hockett,et al.  Kinetics of T cell receptor β, γ, and δ rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44+CD25+ Pro-T thymocytes , 1998 .

[49]  K. Shortman,et al.  Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny , 1996, The Journal of experimental medicine.

[50]  S. Tonegawa,et al.  Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. , 1994, Journal of immunology.

[51]  C. Mackall,et al.  A dose effect of IL-7 on thymocyte development. , 2004, Blood.

[52]  B. Roser,et al.  Differences in turnover between thymic medullary dendritic cells and a subset of cortical macrophages. , 1990, Journal of immunology.

[53]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[54]  D. Andrew,et al.  IL-7 and Not Stem Cell Factor Reverses Both the Increase in Apoptosis and the Decline in Thymopoiesis Seen in Aged Mice1 , 2001, The Journal of Immunology.

[55]  C. Benoist,et al.  Intrathymic delivery of MHC genes using recombinant adenoviruses. , 2000, Methods in molecular biology.

[56]  Li Wu,et al.  Early T lymphocyte progenitors. , 1996, Annual review of immunology.